Primary Nonfunction and Early Allograft Dysfunction after Liver Transplantation

Area of Science:

• Hepatology
• Transplantation Surgery
• Immunology

Background:

• Postoperative graft dysfunction, including early allograft dysfunction (EAD) and primary nonfunction (PNF), significantly impacts liver transplant outcomes.
• These conditions arise from multifactorial causes, including donor, recipient, and procedural factors, with ischemia-reperfusion injury being a primary contributor.

Purpose of the Study:

• To present the current diagnostic, predictive, and management approaches for EAD and PNF in liver transplantation.
• To review existing and emerging strategies aimed at mitigating the negative effects of ischemia-reperfusion injury.

Main Methods:

• Review of current literature on liver transplantation, focusing on graft dysfunction.
• Analysis of noninvasive (pharmacological) and invasive strategies for managing EAD and PNF.
• Evaluation of the efficacy of different interventions, including machine perfusion.

Main Results:

• Ischemia-reperfusion injury is a key factor in the development of EAD and PNF.
• Various pharmacological and invasive strategies have been explored to reduce graft dysfunction.
• Machine perfusion is identified as a potentially highly effective method for improving graft function post-transplantation.

Conclusions:

• Effective management of EAD and PNF is crucial for improving patient outcomes after liver transplantation.
• A combination of donor, recipient, and procedural management is necessary.
• Machine perfusion demonstrates significant promise as an intervention to enhance graft viability and function.